Literature DB >> 30361912

Predictive Factors of Lateral Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.

Wenjing Zhao1, Shaobo Chen2, Xianming Hou2, Quan Liao2, Ge Chen3, Yupei Zhao4.   

Abstract

This study was designed to determine the incidence and predictive factors for lateral lymph node metastasis (LNM) in patients with papillary thyroid microcarcinoma (PTMC). From January 2014 to July 2015, a retrospective review was conducted of 215 patients with PTMC who underwent total thyroidectomy and central lymph node dissection (LND) with lateral LND. Correlations of lateral LNM with clinicopathological features were examined using univariate analyses. Risk factors for lateral LNM were identified by multivariate analysis. Lateral LNM was observed in 163(75.8%) cases of 215 patients and often involved in level III (82.2%) and level IV (65.6%), with most found in two-levels (41.1%) and single-level (33.7%) models. Multivariate analyses showed that central LNM (odds ratio [OR]: 8.28, 95% confidence interval [CI]: 3.43-19.98, p < 0.001) and upper portion location (OR: 2.87 [CI: 1.34-6.09]; p = 0.007) were independent predictive factors for lateral LNM. The incidence of skip metastasis-Lateral LNM with central Lymph nodes negative-was 8.6% (14/163). Age ≥ 45 years old (OR: 4.37 [CI: 1.14-16.66]; p = 0.031) and upper portion location (OR: 4.34 [CI: 1.27-14.78]; p = 0.019) were independent risk factors for skip metastasis by multivariate analyses. Taken together, patients with PTMC with central LNM and tumor in the upper pole were more likely to present with lateral LNM. Even if there was no central LNM, patients with an age ≥ 45 years old and tumors in the upper portion of the thyroid should be evaluated carefully for possible lateral LNM.

Entities:  

Keywords:  Lateral lymph node metastasis; Papillary thyroid microcarcinoma; Predictors; Skip metastasis

Mesh:

Year:  2018        PMID: 30361912     DOI: 10.1007/s12253-018-0511-8

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  6 in total

1.  Mitoxantrone hydrochloride injection for tracing helps to decrease parathyroid gland resection and increase lymph node yield in thyroid cancer surgery: a randomized clinical trial.

Authors:  Shaobo Chen; Xianming Hou; Surong Hua; Ziwen Liu; Binglu Li; Xiaoyi Li; Lin Cong; Quan Liao; Jugao Fang; Lizhen Hou; Shanghua Jing; Zhen Zhao; Jianwu Qin; Songtao Zhang; Zhendong Li; Dongning Huang; Ning Zhang; Yongfu Zhao; Jun Liu; Shujun Wang; Ge Chen; Yupei Zhao
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

2.  Routine Lateral Level V Dissection May Not Be Necessary for Papillary Thyroid Microcarcinoma With Lateral Lymph Node Metastasis: A Retrospective Study of 252 Cases.

Authors:  Shuai Xue; Peisong Wang; Qiang Zhang; Yue Yin; Liang Guo; Ming Wang; Meishan Jin; Guang Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-20       Impact factor: 5.555

3.  PTC located in the upper pole is more prone to lateral lymph node metastasis and skip metastasis.

Authors:  Yi Dou; Daixing Hu; Yingji Chen; Wei Xiong; Qi Xiao; Xinliang Su
Journal:  World J Surg Oncol       Date:  2020-07-28       Impact factor: 2.754

4.  Nomograms for the prediction of lateral lymph node metastasis in papillary thyroid carcinoma: Stratification by size.

Authors:  Jia-Wei Feng; Jing Ye; Li-Zhao Hong; Jun Hu; Fei Wang; Sheng-Yong Liu; Yong Jiang; Zhen Qu
Journal:  Front Oncol       Date:  2022-09-28       Impact factor: 5.738

5.  Preoperative Sonographic and Clinicopathological Predictors for Solitary Lateral Neck Node Metastasis in Papillary Thyroid Carcinoma: A Retrospective Study.

Authors:  Qiong Yang; Pei Chen; Hui-Yu Hu; Hai-Long Tan; Gui-You Li; Mian Liu; Deng-Jie Ou-Yang; Rooh-Afza Khushbu; Deepak Pun; Zhi-Peng Zhang; Peng Huang; Shi Chang
Journal:  Cancer Manag Res       Date:  2020-03-12       Impact factor: 3.989

6.  Lateral Lymph Node Metastases in T1a Papillary Thyroid Carcinoma: Stratification by Tumor Location and Size.

Authors:  Xiaojun Zhang; Wenkuan Chen; Qigen Fang; Jie Fan; Lu Feng; Lanwei Guo; Shanting Liu; Hong Ge; Wei Du
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-15       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.